Table 1. Clinical and histopathological characteristics of the patients under study.

	n	%
Age
Median	54.3
Q1-q3	46.5–64.9
Stage
III	214	89.17
IV	26	10.83
First line treatment
Cisplatin	90	37.5
Cisplatin + Taxol	100	41.67
Taxol	2	0.83
Other	48	20
Grade
Borderline	6	2.5
1	15	6.25
2	64	26.67
3	155	64.58
Histotype
serous	187	77.92
endometrioid	22	9.17
clearcell	13	5.42
mucinous	8	3.33
undifferentiated	7	2.92
Other	3	1.25
Tumorresidual
<2 cm	87	36.25
>2 cm	153	63.75
NED/micro	41	17.08
<1 cm	30	12.5
1-2 cm	16	6.67
2-5 cm	36	15
5-10 cm	52	21.67
>10 cm	65	27.08